[
    {
        "utterance": "Fanny Chapelin: ping tools to track inflammation and uh cancer response to therapy. ",
        "annotations": {
            "present new idea": "The utterance introduces a new concept of using 'ping tools' to track inflammation and cancer response to therapy, which hasn't been previously mentioned."
        }
    },
    {
        "utterance": "Brad Smith: Uh Crystal, you're um keep reading these names. ",
        "annotations": {
            "assign task": "Brad Smith is assigning Crystal the task of reading the names, as indicated by the phrase \"you're um keep reading these names.\""
        }
    },
    {
        "utterance": "Crystal Rogers: I'm I'm Crystal Rogers from UC Davis. I am a developmental biologist, so I do a lot of um fluorescence imaging of fixed and live cells uh during morphogenesis and watching cells, I focus on neural crest cells which start out epithelial, undergo EMT and migrate. And so I'm really happy to be put in this room and hoping I can pick all of your brains. ",
        "annotations": {
            "explain or define term or concept": "The speaker is explaining her background and research focus, defining her expertise in developmental biology and fluorescence imaging.",
            "express enthusiasm": "The speaker expresses happiness about being in the room and hopes to learn from others, indicating enthusiasm for the collaboration."
        }
    },
    {
        "utterance": "Brad Smith: Uh Mimi? ",
        "annotations": {
            "encourage participation": "Brad Smith is inviting Mimi to introduce herself and contribute to the conversation, similar to how he asked Crystal to speak previously."
        }
    },
    {
        "utterance": "Mimi Sammarco: Uh, I'm Mimi Sammarco and I'm at Tulane School of Medicine down in New Orleans. Um, I work on bone and soft tissue regeneration, so um, I do a lot of chemistry, so fixed fluorescent imaging and then um live cell imaging. Um, and just trying to figure out uh better ways to get around imaging hard tissue like bone so that we can answer some longitudinal questions about growth. ",
        "annotations": {
            "explain or define term or concept": "Mimi is explaining her background and research focus, which involves bone and soft tissue regeneration, chemistry, fixed fluorescent imaging, and live cell imaging, to provide context for the group.",
            "present new idea": "Mimi introduces the idea of finding better ways to image hard tissue like bone to answer longitudinal questions about growth, which is a novel research direction within the conversation."
        }
    },
    {
        "utterance": "Brad Smith: Uh, Sweat. ",
        "annotations": {
            "encourage participation": "Brad Smith is inviting Sweat to introduce themselves, similar to how he prompted Crystal and Mimi to speak."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh yeah, so um, so I'm a new professor at UT Austin. Um just joined one or two months ago. So I research uh interests revolve around uh building optical imaging devices for high resolution imaging, but also for computational imaging to be able to uh combine computation and hardware in a way that allows imaging systems to see things that are otherwise not possible. Um yeah, and hopefully uh this and this is all targeting like biomedical or clinical imaging uh imaging needs. ",
        "annotations": [
            {
                "explain or define term or concept": "The speaker explains his research interests involve building optical imaging devices for high resolution imaging and computational imaging."
            }
        ]
    },
    {
        "utterance": "Brad Smith: Allison. ",
        "annotations": {
            "encourage participation": "Brad Smith is inviting Allison to introduce herself and contribute to the conversation, as he has done with the previous participants."
        }
    },
    {
        "utterance": "Allison Dennis: Hi, I'm Allison Dennis. I'm at Boston University in BME, Biomedical Engineering and Material Science Engineering. My lab does material science development of semiconductor nanocrystals. So um, you know, fluorescent quantum dots that emit anywhere from the UV through the visible near infrared and um moving into the sphere now um for both um fluorescence imaging as well as fluorescence biosensing. So we're really excited moving forward um looking at taking some of our fret based fluorescent biosensors and uh developing them for swear imaging for in vivo use um and uh uh one of our we're trying to make some translational materials also. So starting with biocompatible and biodegradable semiconductor nanocrystals and then developing their optical properties rather than starting with things first made for solar cells and uh LED lights, maybe make them for a biological approach and then develop the optical things. So um those don't always fluoresce, so we're accidentally making some photoacoustic imaging and photothermal therapy um particles on accident as it happens. Thanks. ",
        "annotations": [
            {
                "explain or define term or concept": "The speaker explains that their lab develops semiconductor nanocrystals, specifically fluorescent quantum dots, clarifying their area of expertise."
            },
            {
                "present new idea": "The speaker introduces the idea of developing biocompatible and biodegradable semiconductor nanocrystals for biological applications, which is a novel approach compared to using materials designed for solar cells and LEDs."
            },
            {
                "express enthusiasm": "The speaker expresses excitement about moving forward with their research, indicating a positive outlook on their work."
            }
        ]
    },
    {
        "utterance": "Brad Smith: Thank you. Uh Ping. ",
        "annotations": {
            "acknowledge contribution": "Brad Smith thanks Allison for her introduction, acknowledging her contribution to the conversation.",
            "encourage participation": "Brad Smith then calls on Ping to introduce themself, encouraging their participation."
        }
    },
    {
        "utterance": "Ping Wang: Hi everyone. Uh I'm Ping Wang from Michigan State. Um, I'm a faculty member in radiology. Uh, so uh my uh the research work in my lab focus on molecular imaging of diabetes. Uh, particularly uh we are interested in uh cell using the imaging modality to track um the transplanted eyelid cells and also the stem cells for the type one diabetes. Uh, the imaging modalities we often to use uh include include uh MRI, pet MRI, um and magnetic particle imaging. Um, and also we use the optical imaging for the cells. Um, I I am very much um looking forward to uh working with you and generate some good great ideas. ",
        "annotations": [
            {
                "explain or define term or concept": "The speaker explains their research focus on molecular imaging of diabetes, including tracking transplanted islet and stem cells for type 1 diabetes, which clarifies their area of expertise for the group."
            },
            {
                "provide supporting evidence": "The speaker mentions specific imaging modalities used in their research, such as MRI, PET MRI, magnetic particle imaging, and optical imaging, to provide concrete examples of their work."
            },
            {
                "express enthusiasm": "The speaker expresses enthusiasm about working with the group and generating new ideas, indicating a positive and collaborative attitude."
            }
        ]
    },
    {
        "utterance": "Brad Smith: Arnold. ",
        "annotations": {
            "encourage participation": "Brad Smith is inviting Arnold to introduce himself and contribute to the conversation, continuing the round of introductions."
        }
    },
    {
        "utterance": "Arnold Hayer: Hi, my name is Arnold Hayer. I'm a an assistant professor at McGill University in the Department of Biology. I've run my lab now for about three years. And uh the research program that we are pursuing is uh interested in understanding the signaling networks that govern cell migration and we are using cultured endothelial cells as a model system and we're interested in both the signaling dynamics in individual cells um but also how these signaling dynamics in individual cells are coordinated between neighboring cells during collective cell migration. And uh we have a a two-dimensional model for collective cell migration which is basically just monolayers and cells are moving within the monolayers but also three-dimensional migration and and morphogenesis, which is something endothelial cells do. So a lot of our work relies on fluorescence imaging using um probes, reporters for cytoskeletal structures or for um for fret based fret based probes for activities such as ro GTPases. So we're tracking cells but in in in single cells we're also tracking um regions of cells like protrusions, retractions and trying to relate those morphogenetic processes to signaling activities. ",
        "annotations": [
            {
                "explain or define term or concept": "The speaker explains their research program, focusing on signaling networks governing cell migration, using cultured endothelial cells as a model system, and tracking signaling dynamics in individual and collective cell migration."
            }
        ]
    },
    {
        "utterance": "Brad Smith: Ferdinand. ",
        "annotations": [
            {
                "encourage participation": "Brad Smith is inviting Ferdinand to introduce himself and his research interests to the group, continuing the round of introductions."
            }
        ]
    },
    {
        "utterance": "Ferdinand Schweser: Yeah, I work at the University at Buffalo. my training I'm a physicist by training and uh work in the MRI field now. Um my own research uh combines uh mathematics, computer science, physics and biomedical imaging uh to um turn MRI into a measurement instrument so we can really use it to quantify physical tissue properties specifically um related to magnetization. Um actually I have also a second head and I'm technical director of our imaging facility and there we actually involved also in cell tracking studies um also with MRI but also pet MRI and uh pet pre clinical and clinical. ",
        "annotations": [
            {
                "explain or define term or concept": "The speaker explains that his research aims to turn MRI into a measurement instrument to quantify physical tissue properties, specifically related to magnetization, which clarifies the application of MRI in his work."
            }
        ]
    },
    {
        "utterance": "Brad Smith: And Mark. ",
        "annotations": {
            "encourage participation": "Brad Smith is inviting Mark to introduce himself and his work, similar to how he invited Crystal, Mimi, Sweat, Allison, Ping, Arnold, and Ferdinand to speak."
        }
    },
    {
        "utterance": "Mark Selimyer: Hi everyone, I'm Mark Selmeyer um at the University of Pennsylvania. I'm a um one day a week clinician as a nuclear radiologist and uh four to five to six day a week, you know, scientist in the lab and uh the fields I work in are predominantly chemical biology and molecular imaging from the combination of the two are sort of interrelated. So we have some um synthetic chemistry efforts in the lab. Um, I'd say the the areas that we're the most focus on right now are imaging of infectious diseases. So one is how do you monitor bacteria trafficking around an animal or a human. So we do pet reporter um pet probe approaches for that. And then the second area that's kind of germaine to this topic is really the imaging and control of gene and cell therapies. And so if you look at, you know, the next breakthrough or pillar of medical therapies, it's probably going to come through these engineered systems where viruses and cells have been made to treat people's diseases and how do we get assessments of those um those therapies in situ. ",
        "annotations": [
            {
                "explain or define term or concept": "The speaker explains their role as a clinician and scientist, providing context for their expertise.",
                "present new idea": "The speaker introduces their research areas, including imaging of infectious diseases and imaging/control of gene and cell therapies, which are new topics in the conversation."
            }
        ]
    },
    {
        "utterance": "Brad Smith: Well, thank you. Um we're supposed to spend this 30 seconds to to write down an idea. So maybe we don't have to all do that, but um but but if if we have a bit of dead time, we may go back to that. But uh Brian, do you have a sort of thought about the big start off questions? ",
        "annotations": {
            "acknowledge contribution": {
                "Explanation": "Brad Smith thanks the previous speaker for their introduction."
            },
            "assign task": {
                "Explanation": "Brad Smith asks Brian for his thoughts on the starting questions, assigning him the task of providing input."
            },
            "encourage participation": {
                "Explanation": "Brad Smith encourages Brian to participate by asking for his thoughts."
            }
        }
    },
    {
        "utterance": "Brian Pogue: Yeah, so we are very sorry what is it? So we're tracking. ",
        "annotations": [
            {
                "explain or define term or concept": "Brian is likely trying to clarify or define the concept of 'tracking' based on the previous introductions where researchers mentioned tracking cells and other biological processes using imaging techniques."
            }
        ]
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um to clarify. ",
        "annotations": {
            "ask clarifying question": "Shwetadwip is asking a clarifying question, likely referring to the previous discussion about tracking."
        }
    },
    {
        "utterance": "Brian Pogue: No, no, no, just on a piece of paper, you know, word document, whatever, just you know, your thoughts. ",
        "annotations": [
            {
                "explain or define term or concept": "Brian is clarifying that the 'idea' he mentioned earlier should be written down on any medium, such as paper or a word document."
            }
        ]
    },
    {
        "utterance": "Brad Smith, Notre Dame: And these sessions here now are really to sort of get to know groups that may be able to interact. Um, so this particular session, all it ends up has to be is one one slide in a slide deck, but it's within this group that maybe a couple of individuals identify complementary skills or we're trying to identify maybe the bigger questions that some people may want to pursue. So it's sort of free form, but I'm giving you a sense of where it all ends up. So the report out is to say we'll just be a simple slide, we're not going to write a paper or anything from this session. And uh, but it but it it is important for us to get a a bit of input from everybody. ",
        "annotations": {
            "explain or define term or concept": "Brad Smith is explaining the purpose and format of the current session, clarifying that it's for identifying potential collaborations and will result in a single slide presentation.",
            "encourage participation": "Brad Smith encourages input from everyone in the group, emphasizing its importance for the session's goals."
        }
    },
    {
        "utterance": "Brad Smith, Notre Dame: Um, obviously some people are very passionate and very expert about this, but but this is also an opportunity for somebody who maybe hasn't who's thought about this area but really hasn't thought how they could get into it and suddenly maybe there is a way that they can get into the game. If they first of all just we know what the question is. Um, you know, where are the technology gaps or and uh, you know, obviously the big one that immediately comes up is we have a clinical set of questions and a pre-clinical set of questions. ",
        "annotations": {
            "encourage participation": "Brad Smith is encouraging those who haven't deeply considered the area to see how they might contribute, building on the previous context of introducing the session's goals.",
            "present new idea": "Brad Smith introduces the idea of identifying technology gaps and clinical vs. pre-clinical questions, which is a new direction for the group to consider based on the previous discussion about the session's goals."
        }
    },
    {
        "utterance": "Brad Smith, Notre Dame: Yeah. ",
        "annotations": {
            "express agreement": "Brad Smith agrees with a prior statement or idea, indicated by the use of \"Yeah.\""
        }
    },
    {
        "utterance": "Ferdinand Schweser, SUNY UB: So then we what are we supposed to do then? We just uh say our our thoughts or uh how is it started? ",
        "annotations": {
            "ask clarifying question": "Ferdinand is asking for clarification on what the group is supposed to do next, given Brad's explanation of the session's goals."
        }
    },
    {
        "utterance": "Brad Smith, Notre Dame: Well, Brian, you I mean if you've got a good idea, but it seemed to me that that there may be there is a set of questions around clinical questions and then there's a set of questions about the microscopy and pre-clinical. I don't know if that's two sets of frameworks to begin trying to identify questions, but uh I'll throw that out as and then I'll let you choose which one you would want to do. ",
        "annotations": {
            "present new idea": "Brad Smith introduces the idea of framing the discussion around two sets of questions: clinical and pre-clinical, which hasn't been explicitly proposed before.",
            "propose decision": "Brad Smith proposes that they can choose which set of questions (clinical or pre-clinical) they want to focus on, suggesting a direction for the group's discussion."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah, or even a variant of that. Are there, you know, those we I think this is easily addressed pre in vitro, right? So we all have single cell imaging tools that we are aware of or use in vitro and then which of those translate to in vivo and then which of them could translate to to human in vivo. Um, ",
        "annotations": {
            "expand on existing idea": "Brian is building on Brad's suggestion of clinical and pre-clinical questions by suggesting a variant that considers in vitro, in vivo, and human in vivo applications.",
            "propose decision": "Brian is suggesting to consider which single cell imaging tools translate from in vitro to in vivo and then to human in vivo."
        }
    },
    {
        "utterance": "Ferdinand Schweser, SUNY UB: I think we already uh tracking single cells with MRI. Uh, you can load uh cells with a lot of iron, for example. I'm not quite sure about the sensitivity, but at least to uh small set of cells you can down to that, get down to that uh sensitivity. ",
        "annotations": {
            "expand on existing idea": "Ferdinand is expanding on the idea of tracking single cells, which was brought up by Brian in the previous utterance, by stating that they are already tracking single cells with MRI.",
            "provide supporting evidence": "Ferdinand provides supporting evidence for tracking single cells with MRI by mentioning that cells can be loaded with iron to enhance MRI visibility.",
            "explain or define term or concept": "Ferdinand explains the concept of tracking single cells with MRI by providing an example of how it can be done (loading cells with iron).",
            "present new idea": "Ferdinand presents the idea of loading cells with iron to track them with MRI, which is a novel approach not previously mentioned in the conversation."
        }
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: Yeah, that's one of the big issues in MRI. You can see subsets of cells, but you can't get to the single cell level. ",
        "annotations": {
            "provide supporting evidence": "Fanny states that one of the big issues in MRI is that you can see subsets of cells, but not at the single cell level, supporting the previous statement about MRI sensitivity.",
            "expand on existing idea": "Fanny expands on the previous idea of tracking single cells with MRI by stating that it is difficult to get to the single cell level."
        }
    },
    {
        "utterance": "Ferdinand Schweser, SUNY UB: Yeah. ",
        "annotations": {
            "express agreement": "Ferdinand agrees with Fanny's statement that MRI has issues with single-cell resolution, building on the discussion about MRI's capabilities for tracking single cells."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: you know, there are issues with how much the loading affects the cell property or survival or or ",
        "annotations": {
            "expand on existing idea": "Ferdinand mentioned tracking single cells with MRI, and Brian expands on this idea by pointing out issues with how loading cells affects their properties or survival, building on the discussion of MRI cell tracking."
        }
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: Absolutely. ",
        "annotations": {
            "express agreement": "Fanny explicitly agrees with Brian's statement about the issues with how much loading affects the cell property or survival."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: And um does anybody know much about that? ",
        "annotations": {
            "encourage participation": "Brian is asking if anyone has knowledge about the effect of cell loading on cell properties, survival, etc., encouraging someone to contribute to the discussion."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): I think I think, you know, I I one way to structure this conversation would be to start with like organism and pre-clinical and then move towards the clinical because I think the challenges get ordina, you know, much much more difficult as you get to clinical imaging and you know, what's known out there is uh um there's a lot less. And so I I think if you think about like organisms that we care about, that might be a a place to start. I don't know if there are any zebrafish biologists on on in this group, but there's, you know, a translucent organism that is amenable to fluorescence, right? ",
        "annotations": {
            "propose decision": {
                "Explanation": "Mark proposes a way to structure the conversation, suggesting to start with organism and pre-clinical studies and then move towards clinical studies, because the challenges get more difficult as you get to clinical imaging."
            },
            "present new idea": {
                "Explanation": "Mark introduces the idea of focusing on organisms that are amenable to fluorescence, such as zebrafish, as a starting point for the discussion, which is a novel suggestion in the context of the conversation."
            }
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): But but I guess yeah, that that's my take on how to structure it because um starting simple I think would be good. ",
        "annotations": {
            "propose decision": "Mark Selimyer suggests structuring the conversation by starting with simpler organisms and pre-clinical studies before moving to clinical applications, proposing a way to organize the discussion."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah. And in some ways we're we're supposed to just facilitate the discussion you you folks are actually supposed to do the discussion. So we're going to push along here but actually uh we've been intentionally told not to drive the discussion. So ",
        "annotations": {
            "encourage participation": "Brian encourages the group to lead the discussion, reminding them that they are supposed to be the ones actively participating, following the instructions they were given.",
            "assign task": "Brian indirectly assigns the task of leading the discussion to the group members, clarifying that their role is to facilitate, not drive, the conversation."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: Sure. ",
        "annotations": {
            "express agreement": "Shwetadwip Chowdhury expresses agreement with Brian Pogue's statement that they are intentionally told not to drive the discussion."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: I think the question is if if we really want to see uh an ensemble of single cells and then see how it migrates within a very small scale. ",
        "annotations": {
            "present new idea": "The speaker introduces the idea of observing an ensemble of single cells and their migration within a small scale, which is a novel concept in the context of the discussion."
        }
    },
    {
        "utterance": "Ferdinand Schweser, SUNY UB: So uh do you are you interested in us in a length scale of say 1 millimeter or 100 micrometer and want to see or several hundred micrometers and see how the cells migrate in there or are you interested in certain cells how they migrate from one brain region to the other? Because that's a very different um problem with MRI, the resolution for example also with pet, the resolution is so low that it's probably I shouldn't say never here but very difficult to uh get to a high spatial resolution. If you have a cell on the left hemisphere and one or a bunch of cells on the left hemisphere and a bunch of cells on the right hemisphere, you can probably see how uh these sets of cells migrate relative to one another, but uh with in the resolution, the imaging technique it will be difficult. ",
        "annotations": [
            {
                "ask clarifying question": "The speaker is asking about the length scale of interest (1mm vs. 100 micrometers) to understand the specific imaging requirements, building on the discussion about single-cell tracking and migration."
            },
            {
                "explain or define term or concept": "The speaker explains the limitations of MRI and PET in achieving high spatial resolution for cell tracking, elaborating on the challenges mentioned earlier regarding single-cell imaging with MRI."
            }
        ]
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: It would be nice if it left a path. I tend to see like where something starts and where it ends and it'll cross like at least in time it'll cross some sort of perimeter, but I can't tell like where it went. And I was talking with my I don't know my grad student a while back and we were talking about how it would be cool to have something, I mean something ubiquitous in the ECM like collagen where you could it would actually leave a path as it went from point A to point B. I don't know whether it would be whether it's fret, whether it's something else. I think that would be technically it would be tracking in vitro because you'd be looking at the path or in or in vivo. You'd be looking at a path it set in vivo, but not necessarily the endpoint would have to be like a section or something like that. ",
        "annotations": [
            {
                "present new idea": "The speaker introduces the idea of having cells leave a path as they migrate, which hasn't been discussed before."
            },
            {
                "expand on existing idea": "The speaker expands on the idea of tracking cell migration by suggesting a method where cells leave a path in the ECM, building upon the previous discussion about tracking single cells with MRI and the challenges of single-cell resolution."
            }
        ]
    },
    {
        "utterance": "Mark Selimyer (UPenn): Oh, that's that's ",
        "annotations": {
            "acknowledge contribution": "Mark acknowledges Mimi's idea about tracking cell migration paths, but the utterance is cut short so it is unclear if he agrees or expands on the idea."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Oh, that's that's that's cool Mimi and I I think we've been thinking about that type of stuff uh how to track um kissing partners if you will of cells over like long periods of time. And so actually Gabrielle Victoria's group in New York had made a a system that lets immune cells label other immune cells that they've interact with using using um an engineered protein that's on the cell surface that will um take an a epitope and ligate that on through a bacterial protein that light light that does, you know, cross ligations and so the technology is called lipstick. You can look if you're interested uh appropriately of labeling these cells and so that gives you that kind of trail blazer type of um, you know, lighting a fire against as as you blaze a path through a particular tissue. And this is actually done in mice, so it's pretty cool. ",
        "annotations": [
            {
                "express agreement": "Mark expresses agreement with Mimi's idea of tracking cells by leaving a path, indicating that he and his team have been considering similar approaches.",
                "provide supporting evidence": "Mark provides supporting evidence by referencing Gabrielle Victoria's group in New York and their 'lipstick' technology, which allows immune cells to label other immune cells they interact with, creating a trail."
            }
        ]
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Does it leave a fluorescent trail? ",
        "annotations": {
            "ask clarifying question": "Mimi is asking a question to clarify whether the 'lipstick' technology, mentioned by Mark, leaves a fluorescent trail, seeking more details about its mechanism."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Fluorescence, yeah, it's a fluorescent mark on the cell surface of of neighboring cells that have walked by. ",
        "annotations": {
            "expand on existing idea": "Mark is expanding on Mimi's idea of leaving a path by describing a technology called lipstick that leaves a fluorescent mark on the cell surface of neighboring cells that have walked by, building upon the concept of tracking cell interactions over time.",
            "provide supporting evidence": "Mark is providing supporting evidence for the feasibility of tracking cell interactions by referencing Gabrielle Victoria's group in New York and their lipstick technology, which uses an engineered protein to label interacting immune cells with a fluorescent mark."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Oh, candy. ",
        "annotations": {
            "express humor": "Mimi expresses humor with the word \"candy\" after Mark describes a method of fluorescently labeling cells that have interacted with each other, implying the fluorescent trail is appealing."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: So for a whole body frozen section imaging. ",
        "annotations": {
            "present new idea": "Brian Pogue introduces the idea of whole body frozen section imaging, which hasn't been discussed previously in the conversation."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Yeah. I mean or you could throw a whole bunch of tiny little hearts or feet or whatever in there and uh it actually it the blades are nice enough where they go pretty well through the bone. I've been trying to talk to Tulane into getting one, but I've had no luck so far. Um I mean what's the emit imaging system? The emit um I don't know if you guys are familiar with it, but it's it's amazing. It's uh basically you just flash freeze a mouse. Um you'd have to have some sort of signal in it. It'll do I mean you can you basically turn an entire mouse into 20 micrometer sections. And so what it'll do is it's this giant knife that comes across and shaves off these cryo sections of this mouse. And then it'll it'll image and then reconstruct the entire whatever you imaged into a three-dimensional it's like an Ivis but with way, way better resolution than an Ivis. So ",
        "annotations": [
            {
                "expand on existing idea": "Mimi is expanding on the idea of tracking cells by suggesting a method of using a whole body frozen section imaging system, building upon the previous discussion of cell tracking methods."
            },
            {
                "explain or define term or concept": "Mimi explains the emit imaging system, describing its process of flash freezing a mouse, sectioning it, imaging, and reconstructing a 3D image, after mentioning it."
            },
            {
                "express frustration": "Mimi expresses frustration about not being able to convince Tulane to acquire the emit imaging system, after describing the system."
            }
        ]
    },
    {
        "utterance": "Mark Selimyer (UPenn): Yeah. ",
        "annotations": {
            "express agreement": "Mark simply agrees with the previous statement about the emit imaging system."
        }
    },
    {
        "utterance": "Ferdinand Schweser, SUNY UB: So I was wondering, would it be possible with an infection idea to instead of having a fluorescence marker, have a pet uh agent or have some receptor uh on the infected cells to which a pet agent can uh link so that you can really track over a very long time. So you basically do several snapshots or where you give someone the the pet agent say every week and uh you see light up whatever cells have come in contact with your original infected cell. ",
        "annotations": {
            "present new idea": "Ferdinand proposes a novel approach of using a PET agent or receptor on infected cells instead of a fluorescence marker to track cells over a long period, which hasn't been discussed before.",
            "expand on existing idea": "Ferdinand builds upon the discussion of tracking cells by suggesting a method to track cells over a long time by using PET agents, expanding on the general topic of cell tracking.",
            "propose decision": "Ferdinand suggests using a PET agent or receptor on infected cells for long-term cell tracking, which is a concrete choice for the group to consider."
        }
    },
    {
        "utterance": "Ferdinand Schweser, SUNY UB: Yeah. ",
        "annotations": {
            "express agreement": "Ferdinand expresses agreement with a prior statement, though the specific statement is not clear from the immediate context, but it is likely in response to the previous utterance."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Yeah. ",
        "annotations": {
            "express agreement": "Mark is agreeing with Ferdinand's idea about using a PET agent to track infected cells over a long time, which was just proposed in the previous utterance."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Oh candy. ",
        "annotations": {
            "express humor": "Mimi expresses humor with the interjection \"Oh candy\", which is a lighthearted reaction to the previous discussion about fluorescent trails and PET agents for cell tracking."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah. ",
        "annotations": {
            "express agreement": "Brian Pogue says \"Yeah\" in response to the previous utterance, which expresses an idea, indicating his agreement."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): What's the emit imaging system? ",
        "annotations": {
            "ask clarifying question": "Mark is asking for an explanation or more information about the 'emit imaging system' that Mimi mentioned in the previous utterance."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: The emit um I don't know if you guys are familiar with it, but it's it's amazing. It's uh basically you just flash freeze a mouse. Um you'd have to have some sort of signal in it. It'll do I mean you can you basically you turn an entire mouse into 20 micrometer sections. And so what it'll do is it's this giant knife that comes across and shaves off these cryo sections of this mouse. And then it'll it'll image and then reconstruct the entire whatever you imaged into a three-dimensional it's like an Ivis but with way, way better resolution than an Ivis. So ",
        "annotations": {
            "explain or define term or concept": "Mimi is explaining what the emit imaging system is, describing the process of flash freezing a mouse and creating micrometer sections.",
            "express enthusiasm": "Mimi expresses enthusiasm for the emit imaging system by calling it \"amazing\"."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Yeah. ",
        "annotations": {
            "express agreement": "Mark Selimyer expresses agreement with the previous statement."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah. ",
        "annotations": {
            "express agreement": "Brian agrees with the previous statement made by Mark."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: So ",
        "annotations": [
            {
                "None": "This utterance is incomplete and does not express any idea, question, or decision."
            }
        ]
    },
    {
        "utterance": "Ferdinand Schweser, SUNY UB: So I was wondering, would it be possible with an infection idea to instead of having a fluorescence marker, have a pet uh agent or have some receptor uh on the infected cells to which a pet agent can uh link so that you can really track over a very long time. ",
        "annotations": {
            "present new idea": "Ferdinand introduces the idea of using a PET agent or receptor on infected cells instead of a fluorescence marker to track cells over a long time, which is a novel approach not previously discussed.",
            "expand on existing idea": "Ferdinand builds upon the discussion of tracking cells by suggesting a PET agent or receptor as an alternative to fluorescence markers, expanding on the methods for cell tracking.",
            "propose decision": "Ferdinand proposes the idea of using a PET agent or receptor on infected cells for long-term tracking, suggesting a concrete choice for the group to consider."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Yeah. ",
        "annotations": {
            "express agreement": "The speaker expresses agreement with the immediately preceding idea, which was Ferdinand's suggestion of using a PET agent to track infected cells over a long time."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Yeah. ",
        "annotations": {
            "express agreement": "Mark Selimyer expresses agreement with the previous statement by Ferdinand."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: It seems like it would be better rather than lighting up another cell to light up the ECM because the cells it's lighting up would potentially move or react in relation to whatever you're migrating cell was. ",
        "annotations": {
            "express alternative decision": "Mimi suggests that instead of labeling other cells, it would be better to label the ECM, because the cells that are lit up might move or react in relation to the migrating cell, expressing an alternative to the previous idea of labeling cells that interact with the migrating cell."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Oh, that's ",
        "annotations": {
            "acknowledge contribution": "Mark acknowledges Mimi's contribution regarding the idea of leaving a path to track cell movement, but he doesn't explicitly agree or expand on it."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Oh, that's ",
        "annotations": {
            "acknowledge contribution": "Mark acknowledges Mimi's contribution regarding the idea of leaving a path, but he doesn't explicitly agree or expand on it."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Oh yeah, at least if it's ECM you're laying like a road basically rather than touching. ",
        "annotations": {
            "expand on existing idea": "Mimi is expanding on the idea of tracking cell migration by suggesting to light up the ECM instead of other cells, building upon the previous discussion about tracking cell migration and the challenges of using fluorescent markers or PET agents on cells."
        }
    },
    {
        "utterance": "Ferdinand Schweser, SUNY UB: What is ECM or ACM? ",
        "annotations": {
            "explain or define term or concept": "Ferdinand asks for the definition of 'ECM' or 'ACM', indicating he is seeking clarification on a term used in the discussion."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Oh sorry, um like the extracellular matrix that they're moving through that tends to be more that's just my thought about. ",
        "annotations": {
            "explain or define term or concept": "Mimi defines ECM (extracellular matrix) for Ferdinand, who asked what ECM or ACM was in the previous turn."
        }
    },
    {
        "utterance": "Shwetadwip Choudhury, UT Austin: So I I have a question about this. Um it might be very ignorant, but um so when you have the when you have a uh right now we we've been talking about cells uh interacting with like cells tagging others so that they've interacted with. So the question was how can we follow cells as they migrate? ",
        "annotations": [
            {
                "ask clarifying question": "Shwetadwip is asking a question to clarify the discussion about tracking cell migration and cell interactions, specifically how to follow cells as they migrate, building on the previous discussion about cells tagging each other."
            }
        ]
    },
    {
        "utterance": "Shwetadwip Choudhury, UT Austin: And so I was wondering um if you want to know the migration path of a cell and the cell is probably going to interact with many other types of cells that that have their own migration paths, how why uh would why would they give you the same answer really? Like why would if you wanted to know the migration path of a single cell. ",
        "annotations": {
            "ask clarifying question": "Shwetadwip is questioning the logic of tracking a cell's migration path by observing interactions with other cells, wondering why those interactions would accurately reflect the original cell's path, given that the other cells also have their own migration paths."
        }
    },
    {
        "utterance": "Shwetadwip Choudhury, UT Austin: But you're seeing like a fluorescent blazer blaze trail of all the cells that one particular cell has interacted with, then you're not really getting what you're asking for, right? You're getting more than that. You're getting a lot a lot more than that. So how do you know which which of the blaze trails is the one you want that you care about? ",
        "annotations": {
            "ask clarifying question": "Shwetadwip is questioning the utility of tracking cells by tagging other cells they interact with, because the resulting trail would represent multiple cells' paths, not just the one of interest, and he is asking how to differentiate the trail of the cell of interest from the others.",
            "reject idea": "Shwetadwip is rejecting the idea of tracking cells by tagging other cells they interact with because the resulting trail would represent multiple cells' paths, not just the one of interest."
        }
    },
    {
        "utterance": "Mark Selimyer, UPenn: Yeah, I I think they're different questions, right? One is who are who are the interaction partners of one, you know, particular cell or cell population and then the other is your kind of question what's posed originally in this thing is how do we just follow a set of cells through. ",
        "annotations": {
            "explain or define term or concept": "Mark is clarifying that there are two distinct questions being discussed: identifying interaction partners of cells and tracking a set of cells, which helps to distinguish between the different approaches being considered.",
            "acknowledge contribution": "Mark acknowledges Shwetadwip's question about cell migration paths, recognizing the value of the question being posed."
        }
    },
    {
        "utterance": "Mark Selimyer, UPenn: And the the former is more complex, I think as you're pointing out. The the the just monitoring the like. ",
        "annotations": {
            "acknowledge contribution": {
                "Explanation": "Mark acknowledges Shwetadwip's point about the complexity of tracking cell interactions versus simply following a cell's path, recognizing the validity of the prior contribution."
            }
        }
    },
    {
        "utterance": "Mark Selimyer, UPenn: spatially like I said zebrafish people done, you know, labeling of a fluorescent dye in a neuroprogenitor cell and then watch that dilutionally get expanded through the neural crest or put on a, you know, a on a promoter that's driving, you know, neuro development of a GFP or something like that and then look at okay, this is where all the this is when this gets turned on temporarily in development and then this is, you know, what it looks like at the end of of um of development. ",
        "annotations": {
            "provide supporting evidence": "Mark provides examples of how zebrafish researchers have used fluorescent dyes and GFP to track neuroprogenitor cells and their development, supporting the idea of spatially tracking cells.",
            "expand on existing idea": "Mark expands on the discussion of tracking cell migration by providing specific examples of how it's done in zebrafish using fluorescent dyes and GFP under the control of developmental promoters, building on the previous discussion about cell tracking methods."
        }
    },
    {
        "utterance": "Mark Selimyer, UPenn: And then for bioluminescence imaging which yeah I did some a lot of PhD work in in mice, there you're able to see down to a single very bright cell that's carrying the luciferase in a mouse. ",
        "annotations": {
            "provide supporting evidence": "Mark provides supporting evidence for tracking single cells by mentioning bioluminescence imaging in mice, where a single bright cell carrying luciferase can be seen, building on the discussion about tracking cells."
        }
    },
    {
        "utterance": "Mark Selimyer, UPenn: And then if you transplant that mouse that that single cell that's in a tumor cell, you can watch the development of a primary tumor and the metastatic disease, although bioluminescence as someone pointed out is pretty terrible in terms of spatial resolution. ",
        "annotations": {
            "expand on existing idea": "Mark is expanding on the discussion of cell tracking by describing how bioluminescence imaging can be used to track tumor development and metastasis in mice, building on previous mentions of cell tracking with MRI and other methods.",
            "provide supporting evidence": "Mark provides supporting evidence for the use of bioluminescence imaging by describing how it can be used to track the development of a primary tumor and metastatic disease after transplanting a single luciferase-expressing tumor cell in a mouse.",
            "explain or define term or concept": "Mark explains the limitations of bioluminescence imaging by stating that it has pretty terrible spatial resolution, clarifying a key aspect of this imaging modality in the context of cell tracking."
        }
    },
    {
        "utterance": "Mark Selimyer, UPenn: and it's not particularly quantitative because of the overlying tissues that that absorb a lot of the light coming out of the mouse. But at least there like you're you're suggesting Dr. Chari is is well, you know, you can get. ",
        "annotations": [
            {
                "provide supporting evidence": "The speaker is providing supporting evidence for why bioluminescence imaging is not particularly quantitative, mentioning the overlying tissues that absorb light."
            }
        ]
    },
    {
        "utterance": "Mark Selimyer, UPenn: Okay, the my the the tumor was here and now I see all these metastasis and so that's probably, you know, some cell migration. Stop. ",
        "annotations": {
            "provide supporting evidence": "Mark is providing evidence based on bioluminescence imaging in mice, where they can track the development of a primary tumor and metastatic disease, supporting the idea of cell migration.",
            "expand on existing idea": "Mark is expanding on the discussion about tracking cell migration by providing an example using bioluminescence imaging to track tumor development and metastasis in mice, building upon the previous discussion about different methods for tracking cells."
        }
    },
    {
        "utterance": "Brian Pogue, Dartmouth: Maybe maybe this is a good point to sort of make sure we get everybody's thoughts on um, you know, what examples have you seen where you can do or already do single cell imaging. ",
        "annotations": {
            "encourage participation": "Brian Pogue is trying to facilitate the discussion by inviting everyone to share their experiences with single-cell imaging, building on the previous discussion about tracking cell migration and interactions."
        }
    },
    {
        "utterance": "Brian Pogue, Dartmouth: Um, I don't know, why don't we just start at the top of my screen like Fanny, any have you any experience with single cell imaging? ",
        "annotations": {
            "encourage participation": "Brian is trying to include everyone in the discussion by asking Fanny about her experience with single cell imaging, after a discussion about cell tracking and imaging modalities."
        }
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: Um, in the field of MRI, um, they used very large iron oxide particles to see single cells in the brain. ",
        "annotations": {
            "provide supporting evidence": "Fanny provides an example of how single-cell imaging is done in MRI using large iron oxide particles, supporting the discussion about single-cell imaging techniques that Brian initiated."
        }
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: The issue again is yeah on the viability and um also translatability. Do you want to have such big magnetic beads in your brain? ",
        "annotations": {
            "provide supporting evidence": "Fanny is providing supporting evidence about the limitations of using large iron oxide particles for single cell imaging in the brain, specifically mentioning issues with viability and translatability, building on the previous discussion about MRI and single cell tracking.",
            "ask clarifying question": "Fanny is asking a rhetorical question about the safety of having large magnetic beads in the brain, which is a way of highlighting the translatability issue she mentioned earlier."
        }
    },
    {
        "utterance": "Shwetadwip Choudhury, UT Austin: How do they tag the iron oxide particles to the cells that they care about? ",
        "annotations": {
            "ask clarifying question": "Shwetadwip is asking a question to clarify how iron oxide particles are attached to specific cells of interest, following a discussion about using these particles for single-cell MRI."
        }
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: They incubated uh in the cell culture media before uh infusion and the cells will take it up. ",
        "annotations": {
            "explain or define term or concept": "Fanny explains how iron oxide particles are tagged to cells, clarifying the process of incubation in cell culture media before infusion, which addresses Shwetadwip's question about tagging cells with iron oxide particles."
        }
    },
    {
        "utterance": "Brian Pogue, Dartmouth: Do they take it up or is it sort of hanging on the outside? ",
        "annotations": {
            "ask clarifying question": "Brian is asking Fanny a clarifying question about whether the cells internalize the iron oxide particles or if the particles remain on the cell surface, following Fanny's explanation of using iron oxide particles for single-cell MRI."
        }
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: It's on the inside of the cell. It's inside the cell. ",
        "annotations": {
            "explain or define term or concept": "Fanny clarifies that the iron oxide particles are inside the cell, answering Brian's question about whether the particles are taken up by the cell or just hanging on the outside."
        }
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: Yeah. And actually, I understood the question in a slightly different way because in my field we do a lot of ex vivo labeling and then we track those cells, but here it was about finding the cells in vivo to begin with. That's what I read and I was like, this is hard. Targeting a specific cell population in vivo um is really hard because you're going to have macrophages. ",
        "annotations": [
            {
                "expand on existing idea": "Fanny expands on the discussion about single cell imaging by stating that she understood the question in a slightly different way, focusing on *in vivo* cell tracking rather than *ex vivo* labeling, which is what her field typically does."
            },
            {
                "express frustration": "Fanny expresses frustration by saying that targeting a specific cell population *in vivo* is really hard because of macrophages."
            }
        ]
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: Or any other phagocytic cell picking up your tracer. ",
        "annotations": {
            "expand on existing idea": "Fanny is expanding on her previous point about the challenges of using iron oxide particles to track single cells in vivo, adding that phagocytic cells can also pick up the tracer, complicating the tracking process."
        }
    },
    {
        "utterance": "Fanny Chapelin, UKentucky: And um that will skew your results. ",
        "annotations": {
            "provide supporting evidence": "Fanny is providing supporting evidence to the challenges of using iron oxide particles for single cell imaging in MRI, stating that macrophages or other phagocytic cells picking up the tracer will skew the results, building on the discussion about the viability and translatability of this method."
        }
    },
    {
        "utterance": "Brian Pogue, Dartmouth: Yeah. ",
        "annotations": {
            "Yeah": [
                {
                    "Code Name": "express agreement",
                    "Explanation": "Brian is agreeing with the previous statement made by Fanny about the challenges of targeting specific cell populations in vivo due to macrophages and phagocytic cells picking up the tracer."
                }
            ]
        }
    },
    {
        "utterance": "Ping Wang, MSU: I I just want to add a little bit discussion on that point. Uh so um yeah, we use the similar approach for the cell labeling. ",
        "annotations": [
            {
                "expand on existing idea": "Ping Wang is adding to the discussion about cell labeling techniques, which Fanny Chapelin and Shwetadwip Choudhury were previously discussing."
            }
        ]
    },
    {
        "utterance": "Ping Wang, MSU: So for the for the cell tracking there's like two major uh matters for the like I mean imaging. Uh first one um uh as Fanny said, uh we label the cell pre label the cells in metro. ",
        "annotations": {
            "expand on existing idea": "Ping Wang is expanding on the discussion about cell tracking methods, building on Fanny's previous comments about cell labeling with iron oxide particles for MRI.",
            "acknowledge contribution": "Ping Wang acknowledges Fanny's contribution by referring to her previous statement about cell labeling."
        }
    },
    {
        "utterance": "Ping Wang, MSU: So the cells uh accumulate uh iron oxide nanoparticles. ",
        "annotations": {
            "expand on existing idea": "Ping Wang is expanding on the previously discussed method of cell labeling with iron oxide particles for MRI tracking, which Fanny Chapelin mentioned using in the brain."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Uh then we transplant inject the cells and do the imaging. ",
        "annotations": {
            "expand on existing idea": "Ping Wang is expanding on the previously discussed method of pre-labeling cells with iron oxide nanoparticles for cell tracking, now describing the next step of transplanting/injecting the cells and then imaging them."
        }
    },
    {
        "utterance": "Ping Wang, MSU: We can see the cells. ",
        "annotations": {
            "provide supporting evidence": "Ping Wang is describing their method for cell tracking using iron oxide nanoparticles, and this statement confirms that they are able to visualize the cells after transplantation, providing evidence for their method's success."
        }
    },
    {
        "utterance": "Ping Wang, MSU: The challenge for that is uh especially for MRI, um the resolution. ",
        "annotations": {
            "expand on existing idea": "Ping Wang is expanding on the previously discussed topic of cell labeling with iron oxide nanoparticles for MRI, specifically addressing the challenges associated with this method, which Fanny Chapelin also mentioned."
        }
    },
    {
        "utterance": "Ping Wang, MSU: sensitivity always a problem. But the big problem for that is uh people would ask you like the iron oxide trapped in the cells. ",
        "annotations": {
            "provide supporting evidence": "Ping Wang is providing supporting evidence about the challenges of cell tracking with MRI, specifically mentioning sensitivity as a problem, building on the previous discussion about MRI and cell tracking."
        }
    },
    {
        "utterance": "Ping Wang, MSU: What about the cells die? Die dead cells? ",
        "annotations": {
            "ask clarifying question": "Ping Wang is asking a clarifying question about what happens to the iron oxide trapped in cells when the cells die, which is relevant to the discussion about cell tracking with MRI."
        }
    },
    {
        "utterance": "Ping Wang, MSU: If the cells die, where those iron oxide go? ",
        "annotations": {
            "ask clarifying question": "Ping Wang is asking where the iron oxide goes when the cells die, which is a clarifying question about the fate of the labeling agent after cell death, a concern raised earlier about the use of iron oxide for cell tracking."
        }
    },
    {
        "utterance": "Ping Wang, MSU: So we have to answer that questions. We basically we cannot say okay, all the signals we get from MRI is from live cells. The second second second method probably more um more uh convincing. ",
        "annotations": [
            {
                "provide supporting evidence": "Ping Wang is explaining the limitations of using iron oxide labeling for cell tracking with MRI, specifically that the signal may not only come from live cells, which supports the point about the challenges of this method made in the previous utterances."
            },
            {
                "reject idea": "Ping Wang rejects the idea that all MRI signals come from live cells, highlighting a limitation of the method discussed in the previous utterances."
            },
            {
                "present new idea": "Ping Wang introduces the idea of a second method that is more convincing, suggesting an alternative approach to the current discussion."
            }
        ]
    },
    {
        "utterance": "Ping Wang, MSU: But it as Fanny said it's much more difficult. We develop some target like uh moties and labeled on the nanoparticles. ",
        "annotations": {
            "expand on existing idea": "Ping Wang is expanding on the previously discussed topic of cell labeling techniques, specifically addressing the second method of developing targeted moieties labeled on nanoparticles, which Fanny mentioned is more difficult.",
            "provide supporting evidence": "Ping Wang is providing supporting evidence by mentioning the development of targeted moieties labeled on nanoparticles, which is a method to address the challenges of cell tracking."
        }
    },
    {
        "utterance": "Ping Wang, MSU: We inject the nanoparticle or whatever uh probe you developed and target a particular group of cells. ",
        "annotations": {
            "expand on existing idea": "Ping is expanding on the discussion about cell tracking methods, specifically addressing the second method of targeting a particular group of cells with nanoparticles, which was previously mentioned by Fanny.",
            "present new idea": "Ping is presenting the idea of developing targeted moieties labeled on nanoparticles to target a specific group of cells, which is a novel approach in the context of the discussion."
        }
    },
    {
        "utterance": "Ping Wang, MSU: With that matter, usually we combine with pad imaging. We can answer the question, okay, only the live cells express a particular target. ",
        "annotations": {
            "expand on existing idea": "This sentence expands on the previously discussed method of targeting a particular group of cells by combining it with PET imaging to confirm that only live cells express the target.",
            "provide supporting evidence": "The speaker provides reasoning to strengthen the idea of targeting a particular group of cells, stating that combining it with PET imaging allows them to confirm that only live cells express the target."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Take this like bind bind to these uh probes. Yeah. ",
        "annotations": {
            "provide supporting evidence": "This sentence provides supporting evidence by stating that only live cells expressing a particular target will bind to the probes, supporting the idea of targeting specific cells with labeled nanoparticles."
        }
    },
    {
        "utterance": "Brian Pogue, Dartmouth: Yeah. ",
        "annotations": {
            "express agreement": "Brian Pogue is agreeing with the previous statement made by Ping Wang regarding cell tracking methods."
        }
    },
    {
        "utterance": "Ping Wang, MSU: I think our discussion should be should be focused firstly on what questions we want to answer. Are we are we are we just want to check the cells, see the cells or we want to show like we can prove these cells alive or we can do something like a theranostic can control the function of the cells. ",
        "annotations": {
            "propose decision": {
                "Explanation": "Ping Wang suggests that the discussion should focus on the questions they want to answer, which is a concrete choice for the group to consider, following a discussion about cell tracking methods."
            },
            "ask clarifying question": {
                "Explanation": "Ping Wang asks a series of questions about the goals of cell tracking, such as whether they want to simply see the cells, prove they are alive, or control their function, requesting clarification on the objectives of the research."
            }
        }
    },
    {
        "utterance": "Ping Wang, MSU: I mean, we probably should focus on that part. ",
        "annotations": {
            "propose decision": "Ping suggests that the group should focus on the question of what they want to achieve with cell tracking, such as proving cell viability or controlling cell function, building on the discussion about cell labeling and tracking methods."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Like identify the key questions we want to answer uh for our proposals. And to echo on viability and migration, it's true that if the label moves away, is it moving away because it isn't a live cell or is it moving away because it's been collected by a macrophage and being recycled somewhere else. ",
        "annotations": [
            {
                "propose decision": "Ping Wang suggests that the group should identify the key questions they want to answer for their proposals, building on the discussion about cell tracking and labeling challenges.",
                "expand on existing idea": "Ping Wang expands on the discussion about viability and migration, raising the question of whether label movement indicates cell death or macrophage recycling, which was previously brought up by Fanny and others."
            }
        ]
    },
    {
        "utterance": "Brian Pogue, Dartmouth: Yeah. ",
        "annotations": [
            {
                "express agreement": "Brian Pogue simply says 'Yeah' in response to Ping Wang's comment about the challenges of cell tracking and the need to determine if the label moves away due to cell death or macrophage recycling, indicating agreement with the points made."
            }
        ]
    },
    {
        "utterance": "Crystal Rogers, UC Davis: I I wanted to just note that I am starting to feel really grateful that I study embryos because I'm talking, you know, maximum of like 300 microns of space and we can do a lot of things because they don't have an adaptive immune system that I didn't realize was an issue. ",
        "annotations": [
            {
                "acknowledge contribution": "Crystal acknowledges the challenges discussed regarding cell tracking in vivo, particularly the issue of the adaptive immune system and macrophages affecting results, which she hadn't fully appreciated before, and expresses gratitude for studying embryos where these issues are less prominent."
            }
        ]
    },
    {
        "utterance": "Crystal Rogers, UC Davis: Once you go past the basic questions into the more biomedically relevant questions. Um, and so I think that part of the problem here getting to what Ping was saying is that we actually. ",
        "annotations": [
            {
                "acknowledge contribution": "Crystal acknowledges Ping's prior statement about focusing on the questions they want to answer, indicating she is building upon that idea."
            }
        ]
    },
    {
        "utterance": "Arnold Hayer, McGill: and analysis to achieve that because in 3D you need advanced techniques that are not yet accessible to everyone like lattice light sheet light sheet microscopy and and very reliable computational tools for for tracking individual cells in in those in those systems which I think should in principle be technically possible like tracking in 2D is is pretty trivial in 3D it's much much harder but I think it's it could be done given the imaging techniques that we have then in addition to just tracking it would be nice to have additional properties for each one of the cells like signaling activities some reporters about what's what's going on what state they are what differentiation mode they might have and I I think this is this would potentially allow us to learn more about the fundamental properties of of cellular interactions of organ development which and again if they are not going right then you you would enter a disease state. ",
        "annotations": {
            "expand on existing idea": "Arnold expands on the discussion of single-cell imaging by discussing the need for advanced techniques and analysis for 3D imaging, building on the previous discussion of challenges in single-cell tracking.",
            "present new idea": "Arnold introduces the idea of tracking additional properties of cells, such as signaling activities and differentiation mode, to learn more about cellular interactions and organ development, which is a novel concept in the context of the discussion.",
            "provide supporting evidence": "Arnold supports the need for advanced techniques by stating that tracking in 2D is trivial, but 3D is much harder, implying that advanced techniques are necessary to overcome the challenges in 3D imaging."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: So in um so in optical imaging so my field is optical imaging we uh so we our field specializes in uh imaging resolution um and so we are actually very uh like imaging like cells and even subcellular features are very well within our capabilities. Um but in terms of um but in terms of answering the question about how can we see cells as they migrate through actual organisms the reason that gets difficult is our pain point is imaging through scattering tissue which is whenever you get into bigger biology that's what we struggle with. Like MRI CT pet they we're a lot more um limited by that than the other modalities are. That said uh there is there are a few hybrid approaches are coming in. And so at least for small organisms like um you know like zebrafish or maybe uh even a mouse brain where you like take off the skull and you put like a transmission window through it. In these types of uh specific scenarios there are systems where uh you kind of get pseudo optical resolution but with a lot greater uh penetration depth into the scattering tissue. Um and so I wonder if there's a way to track cells at least in that first millimeter or so depth into the scattering tissue and that might be really important for specific applications where maybe the cell you care about isn't going to go through the whole organism it's only is going to be localized to like the surface areas of the brain or of the spinal cord or whatever. Um and so some technology that I'm really excited about in this space uh like are like of course you have the normal very uh popular optical technologies like confocal and light sheet and stuff like that. ",
        "annotations": [
            {
                "explain or define term or concept": "The speaker explains that their field, optical imaging, specializes in imaging resolution, clarifying their expertise in the context of the discussion on cell tracking."
            },
            {
                "present new idea": "The speaker introduces the idea of hybrid approaches for imaging through scattering tissue, suggesting a potential solution to the challenge of imaging cell migration in larger organisms, which was previously mentioned as a difficulty."
            },
            {
                "expand on existing idea": "The speaker expands on the idea of hybrid approaches by providing specific examples, such as using zebrafish or a mouse brain with a transmission window, building upon the discussion of challenges in imaging cell migration in vivo."
            }
        ]
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: But there are also another another uh set of hybrid imaging techniques that are coming out that are not based on just optics that are that use sound for example like photoacoustics. ",
        "annotations": {
            "expand on existing idea": "Shwetadwip is expanding on the discussion of optical imaging techniques by introducing hybrid imaging techniques that use sound, such as photoacoustics, as an alternative approach."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: Um where they're trying to excite light and based on the heating of the of the sample like acoustic waves come out and you measure that. And one of the benefits of this is that it's a label free. Um so it's basically the contrast it's well it doesn't have to be label free but it was initially presented as label free where the contrast is coming from um absorption. So of course you can introduce exogenous particles that are absorptive to give higher contrast to specific specific components. ",
        "annotations": {
            "explain or define term or concept": "The speaker explains the concept of photoacoustics, where light excitation leads to acoustic wave emission and measurement, highlighting its potential for label-free imaging based on absorption contrast, building on the previous discussion of optical imaging techniques.",
            "expand on existing idea": "The speaker expands on the discussion of optical imaging techniques by introducing photoacoustics as a hybrid imaging method, adding details about its mechanism and contrast generation."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: But um but maybe there's a way like if you have if you know that for cancer you have increased angiogenesis where you have a lot of blood flow. So increased blood flow corresponds to a red shift in your um in your spectra because of how light gets absorbed. So you can image that with uh photoacoustics for example. ",
        "annotations": {
            "present new idea": "The speaker introduces the idea of using photoacoustics to image increased angiogenesis in cancer, which hasn't been explicitly mentioned before.",
            "explain or define term or concept": "The speaker explains how increased blood flow in cancer corresponds to a red shift in the spectra due to light absorption, a concept relevant to photoacoustic imaging.",
            "expand on existing idea": "The speaker expands on the potential of photoacoustics by suggesting it can be used to image increased angiogenesis in cancer due to increased blood flow and the resulting red shift in spectra."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: So I feel like that's also another promising uh technique for this specific situation when you don't when you're not when your question is not about how cells are migrating through the whole large organism but. ",
        "annotations": {
            "expand on existing idea": "Shwetadwip is building upon the discussion of imaging techniques for cell migration, adding photoacoustics as another promising technique, following his previous discussion of optical imaging and hybrid approaches.",
            "express enthusiasm": "Shwetadwip expresses enthusiasm for photoacoustics as a promising technique for cell migration imaging, indicating excitement about its potential."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Mhm. ",
        "annotations": {
            "acknowledge contribution": "Brian Pogue is acknowledging the previous speaker's contribution, but not agreeing or expanding on it."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Yeah. ",
        "annotations": {
            "express agreement": "Ping Wang is agreeing with the previous statement made by Brian Pogue."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: So we we've kind of I've heard people discussing you know we started talking about sort of molecular tagging of like cell cell interactions and causing protein changes and then we've talked a bit about uh model organisms like zebrafish that are transparent things or thin sheets and then now and then we've talked about tools you know that optics gets really high resolution uh MR works kind of and and again there's a lot of nuance to MR single cell imaging. Are there other tools we should be talking about? sounded like people were not in favor of pet but. ",
        "annotations": {
            "expand on existing idea": "Brian summarizes the topics that have been discussed so far, including molecular tagging, model organisms, and imaging tools like optics and MR, building on the previous discussion about different imaging modalities and their applications.",
            "ask clarifying question": "Brian asks if there are other tools that should be discussed, seeking to expand the scope of the conversation beyond the currently mentioned techniques, and he also notes that people were not in favor of PET."
        }
    },
    {
        "utterance": "Ping Wang, MSU: I. ",
        "annotations": [
            {
                "None": "No code applies to this utterance."
            }
        ]
    },
    {
        "utterance": "Ping Wang, MSU: I just I just want to echo on the single cell imaging um. ",
        "annotations": {
            "expand on existing idea": "Ping Wang is building upon the previous discussion about single-cell imaging techniques, as the group was discussing the challenges and tools related to single-cell imaging."
        }
    },
    {
        "utterance": "Ping Wang, MSU: So um I work more like a like towards to the application side so I'm more interested in um MRI pet MRI uh for the clinical translation um I was trained uh as a interventional radiologist. ",
        "annotations": {
            "explain or define term or concept": "Ping Wang is explaining her background and interests, clarifying that she is more focused on the application side, particularly MRI and PET MRI for clinical translation, and that she was trained as an interventional radiologist."
        }
    },
    {
        "utterance": "Ping Wang, MSU: So um for the single cell uh single cell imaging uh for MRI um Eric uh Shapiro group from MSU they published uh like a data for the SPIO iron oxide nanoparticles label they inject to the brain to the mice uh I would say 10 years ago. ",
        "annotations": {
            "provide supporting evidence": "Ping Wang mentions Eric Shapiro's group's publication on SPIO iron oxide nanoparticles injected into mice brains for single-cell imaging with MRI, providing a specific example to support the discussion on single-cell imaging."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Um but as I said you can say the cluster they they claim that's a single cells probably they can do better now with the flow cytometry but back to the 10 years ago people even don't know that was the single cell like feels out cluster. Uh but they show they demonstrate the imaging transplanted cells in brain. ",
        "annotations": {
            "provide supporting evidence": "Ping Wang refers to Eric Shapiro's group's work on SPIO iron oxide nanoparticles to support the discussion on single-cell imaging with MRI, providing a specific example of research in this area.",
            "expand on existing idea": "Ping Wang expands on the discussion of single-cell imaging by mentioning a specific study and its limitations, building upon the previous discussion about the challenges and possibilities of single-cell imaging with MRI."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Last year um uh Sam Gambio's group they published uh pet pet imaging they label they labeled uh uh cells and they inject they because the flow cytometry um I mean work they can they can really get the single cells and they inject to the to the animal. ",
        "annotations": {
            "provide supporting evidence": "Ping Wang mentions Sam Gambio's group publishing pet imaging work where they labeled and injected cells, supporting the feasibility of single-cell imaging with PET."
        }
    },
    {
        "utterance": "Ping Wang, MSU: And the cells ended up in the lung so they they did the pet MRI so they track the cells and they finally they found that single cells in the lung with the histology proofs. ",
        "annotations": {
            "provide supporting evidence": "Ping Wang is providing supporting evidence by mentioning a published study by Sam Gambio's group that used PET/MRI to track single cells to the lung and confirmed their location with histology, which strengthens the discussion about single-cell imaging techniques.",
            "expand on existing idea": "Ping Wang is expanding on the existing idea of single-cell imaging by providing a specific example of a study that successfully used PET/MRI to track cells to the lung, building upon the previous discussion about the challenges and possibilities of single-cell imaging."
        }
    },
    {
        "utterance": "Ping Wang, MSU: So but but for my question is like as I said I'm more interested in translation single cell sounds great but what's the point for the clinical translation? We don't transplanted single cell. ",
        "annotations": {
            "present new idea": "Ping Wang introduces the idea of focusing on the clinical translation aspect of single-cell imaging, questioning its practical relevance since single cells are not typically transplanted.",
            "express alternative decision": "Ping Wang expresses an alternative perspective by questioning the clinical translation relevance of single-cell imaging, implying a different direction for the discussion.",
            "express frustration": "Ping Wang expresses a degree of frustration or skepticism regarding the clinical translation of single-cell imaging, questioning its practical application."
        }
    },
    {
        "utterance": "Ping Wang, MSU: That's only for the for the okay I can show you the resolution can do that probably MRI very difficult some people can show something and for the optical imaging okay we can see the single cells. But you talk about the translation uh I I think because for for my my experience we work on the eyelid transplantation. ",
        "annotations": {
            "reject idea": {
                "Explanation": "Ping Wang dismisses the idea of single-cell imaging as being clinically translatable, implying it's not useful for their work."
            }
        }
    },
    {
        "utterance": "Ping Wang, MSU: We transplanted 1000 islets for mouse for each single mouse. And for the clinical eyelid transplantation you usually need 10,000 eyelid. ",
        "annotations": {
            "provide supporting evidence": "Ping Wang provides the number of islets transplanted in mice (1000) and the number needed for clinical islet transplantation (10,000) to support the point that single-cell imaging may not be directly translatable to clinical applications, building on the previous discussion about single-cell imaging techniques."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Ilets it's like a consist of 2000 cells. It's cell cluster. ",
        "annotations": {
            "explain or define term or concept": "Ping Wang explains that islets, in the context of cell transplantation, are clusters consisting of approximately 2000 cells, clarifying the term 'islet' used in the previous sentences."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Mhm. ",
        "annotations": [
            {
                "acknowledge contribution": "Brian Pogue is acknowledging Ping Wang's point about the challenges of single-cell imaging in clinical translation, where cell clusters are typically transplanted rather than single cells."
            }
        ]
    },
    {
        "utterance": "Ping Wang, MSU: And we also work on the eyelid organoids are differentiate from the induced do you image the eyelid the transplanted eyelids or health or is there imaging that's done as follow up sort of? Yeah we have been published this um like with the with the data from the optical imaging uh MRI imaging we tested um our approach with the small animal model and also the large animal model including the uh bubbles monkey. ",
        "annotations": [
            {
                "ask clarifying question": "Ping Wang asks whether they image the transplanted islets or health, or if there is imaging done as follow-up, seeking clarification on the imaging process related to islet transplantation.",
                "provide supporting evidence": "Ping Wang mentions that they have published data from optical imaging and MRI imaging, and that they tested their approach with small and large animal models, including bubbles monkey, providing evidence of their work on eyelid organoids."
            }
        ]
    },
    {
        "utterance": "Ping Wang, MSU: Yeah. So but as I said uh because because we we need to solve the particular problem. ",
        "annotations": {
            "Ping Wang, MSU": [
                {
                    "Code Name": "present new idea",
                    "Explanation": "Ping Wang is suggesting that the group needs to focus on solving a specific problem, which is a new direction for the discussion."
                }
            ]
        }
    },
    {
        "utterance": "Ping Wang, MSU: For me for me for our field the problem is the transplanted cells going to die. The type one diabetes patients usually they received like eyelid from two donors and 70% of the cells going to die within two weeks after transplantation. So that's only we want to track the cells want to say if this those cells alive. ",
        "annotations": {
            "explain or define term or concept": "The speaker explains the problem in their field, which is that transplanted cells die after transplantation, providing context for the discussion.",
            "provide supporting evidence": "The speaker provides supporting evidence by stating that 70% of transplanted cells die within two weeks after transplantation in type one diabetes patients, highlighting the severity of the problem.",
            "present new idea": "The speaker presents the idea of tracking cells to determine if they are alive, which is a new direction for the discussion."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Of course you can test with the the I mean test the blood glucose tell okay if these cells function but some cells probably they are not like um I mean fully functional but they still alive so probably that's a window for you to do some like rescue treatment. ",
        "annotations": {
            "provide supporting evidence": "The speaker is providing supporting evidence for the need to track transplanted cells by mentioning that blood glucose levels can indicate cell function, but some cells may still be alive even if not fully functional, suggesting a window for rescue treatment.",
            "expand on existing idea": "The speaker is expanding on the existing idea of tracking transplanted cells by discussing how blood glucose levels can be used to assess cell function, building upon the previous discussion about cell viability and migration after transplantation.",
            "present new idea": "The speaker is presenting a new idea by suggesting that even if transplanted cells are not fully functional, they may still be alive, creating a window for rescue treatment, which hasn't been explicitly mentioned before."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah. ",
        "annotations": [
            {
                "express agreement": "Brian Pogue simply expresses agreement with the previous statement by Ping Wang regarding the need to determine if transplanted cells are alive, indicating a shared understanding and validation of the point."
            }
        ]
    },
    {
        "utterance": "Brian Pogue - Dartmouth: So. ",
        "annotations": [
            {
                "None": "This utterance does not contain any content that can be coded."
            }
        ]
    },
    {
        "utterance": "Mark Selimyer (UPenn): I guess you also asked about tools Brian you know what what tools were and I mean I think that um. ",
        "annotations": [
            {
                "acknowledge contribution": "Mark acknowledges Brian's prior question about tools for single-cell imaging, recognizing Brian's input in guiding the discussion."
            }
        ]
    },
    {
        "utterance": "mark selimyer (UPenn): Well the most near and dear to my heart is pet because we get um the sensitivity from the the you know tracer and then you know very low background so it becomes sort of a chemistry and probe development question. How do you get I think Brian we talked earlier about signal to noise being basically the problem of all of us you know in this in this entire you know log is that we're all looking for how to get the best signal to noise and you know pet's going to have the potential for being very high contrast imaging or a lot of signal and so my group does pet reporter gene development in that goal of doing gene and cell therapy imaging. ",
        "annotations": {
            "provide supporting evidence": "Mark explains that PET imaging has high sensitivity due to the tracer and low background, making it a good option for high contrast imaging, which supports his preference for PET.",
            "expand on existing idea": "Mark expands on the discussion about imaging tools by highlighting the advantages of PET imaging, particularly its potential for high contrast imaging and signal, and mentions his group's work on PET reporter gene development.",
            "explain or define term or concept": "Mark explains that the main challenge in imaging is achieving the best signal-to-noise ratio, which is a key concept in the discussion about different imaging modalities."
        }
    },
    {
        "utterance": "mark selimyer (UPenn): And so you know to Ping's question you get around some of the cell death by engineering a gene in that's going to be only expressed in live cells as he said very nicely. ",
        "annotations": {
            "expand on existing idea": "Mark is expanding on Ping's question about cell death by suggesting a solution: engineering a gene that is only expressed in live cells, building upon Ping's concerns about distinguishing live vs dead cells.",
            "acknowledge contribution": "Mark acknowledges Ping's contribution by referring to \"Ping's question\" and saying \"as he said very nicely.\""
        }
    },
    {
        "utterance": "mark selimyer (UPenn): And you think about how pre-clinical imaging was changed by the ciphers and you know microscopy was changed by GFP like it would be phenomenal to have a reporter gene that's non-immunogenic small blah blah blah to be able to get into a clinical you know scenario. ",
        "annotations": {
            "present new idea": "Mark introduces the idea of developing a reporter gene that is non-immunogenic and small for clinical use, drawing an analogy to how ciphers changed pre-clinical imaging and GFP changed microscopy, which is a novel concept in the discussion.",
            "express enthusiasm": "Mark expresses enthusiasm for the potential impact of a new reporter gene for clinical imaging, stating it would be 'phenomenal'.",
            "expand on existing idea": "Mark expands on Ping's earlier point about cell death affecting imaging results by suggesting engineering a gene that is only expressed in live cells to circumvent this issue."
        }
    },
    {
        "utterance": "mark selimyer (UPenn): I think the other one that we should be as a group thinking about and we're less probably experienced even what everyone has sort of said but um is is in ultrasound because there if you're going to get clinical translation you're going to get pretty good depth of penetration of the of the modality. ",
        "annotations": {
            "present new idea": "Mark introduces ultrasound as another tool the group should consider, which hasn't been discussed yet, for clinical translation due to its good depth of penetration.",
            "provide supporting evidence": "Mark mentions that ultrasound has good depth of penetration, which is a reason to consider it for clinical translation, supporting his suggestion."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Micro bubbles. ",
        "annotations": {
            "expand on existing idea": "Mark Selimyer mentioned ultrasound as a tool for clinical translation due to its good depth of penetration, and Ping Wang expands on this by mentioning microbubbles, which are used in ultrasound imaging to enhance contrast."
        }
    },
    {
        "utterance": "mark selimyer (UPenn): Micro bubbles yeah that get that basically again borrowed from a different part of nature the buoyancy operon of bacteria and engineered that into um or of algae the buoyancy operon of algae and engineered it into bacteria to be able to see bacteria expressing those. ",
        "annotations": {
            "expand on existing idea": "Mark is expanding on the previous discussion of ultrasound as a tool by mentioning microbubbles, which are used in ultrasound imaging to enhance contrast and visibility, building upon the discussion of ultrasound as a tool.",
            "explain or define term or concept": "Mark explains that microbubbles are derived from the buoyancy operon of bacteria or algae, clarifying the origin and engineering of these microbubbles for use in imaging."
        }
    },
    {
        "utterance": "mark selimyer (UPenn): And also took that same genetic operon and put it into mammalian cells so that you can put your ultrasound probe on there and then see scattering of air and gas bubbles that the cell is producing itself. And so that's a nice illustration there's a nature paper a couple years ago and then a nature chemical biology paper recently that just that just show um you know a new approach or the the application of a reporter gene using a new physical instrumentation readout. ",
        "annotations": {
            "expand on existing idea": "Mark is expanding on the discussion of ultrasound as a tool by providing a specific example of how genetic operons can be used in mammalian cells to produce gas bubbles for ultrasound imaging, building upon the previous mention of microbubbles.",
            "provide supporting evidence": "Mark mentions a Nature paper and a Nature Chemical Biology paper to support his point about the application of a reporter gene using a new physical instrumentation readout, strengthening his argument with references to published research."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Thanks though micro CT is I mean I I love ultrasound but again with bone and then I deal with areas that have nail and the back scatter we get with ultrasound um really creates some problems at least in some of the models I work with. But it has always seemed to me that micro CT while in clinic you can't really get you know the level of resolution that you can now in animals but I mean the radiation doses you get on some of these small animal images are so small now that you can get very high resolution and still image in the live animal. And so I've always wondered sort of why um you know people haven't sort of focused on um you know contrast like instead of contrast injectable contrast dies but contrast lipids or whatever that would be labeling single cells or that would be I don't know we we talked about actually like injecting iron or like soaking the cells in iron and then trying to chase them around in in our CT one time but of course I didn't have the bandwidth to do that. ",
        "annotations": [
            {
                "expand on existing idea": "Mimi is expanding on the discussion of imaging tools by discussing micro-CT as an alternative to ultrasound, highlighting its advantages in resolution and radiation dose in animal models, building on the previous discussion of imaging tools like PET and ultrasound."
            },
            {
                "present new idea": "Mimi presents the idea of using contrast lipids or other contrast agents to label single cells for micro-CT imaging, which hasn't been explicitly discussed before."
            }
        ]
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: Um but it seems like that would be a better one because you could get penetration that's much deeper and again you don't have to worry these days about the massive radiation doses that you had to. I think the per quantum scans a whole mouse in what under a minute couple of minutes now very high resolution fraction uh 0.5 micrometer box resolution. ",
        "annotations": {
            "expand on existing idea": "Mimi is expanding on the discussion of imaging tools, specifically micro-CT, by highlighting its advantages over ultrasound, such as deeper penetration and reduced radiation doses, building on the previous discussion of various imaging modalities like PET, MRI, and ultrasound.",
            "provide supporting evidence": "Mimi provides supporting evidence for the capabilities of micro-CT by mentioning the speed and resolution of per quantum scans, adding details to support the idea that micro-CT is a viable option for imaging."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: So if you could do that longitudinally and then be able to look at the entire mouse you should be able to track track cell movement over time. But again that would be labeling cells ahead of time not looking at endogenous ones. ",
        "annotations": {
            "expand on existing idea": "Mimi is expanding on the idea of using micro-CT for tracking cell movement, adding that longitudinal studies are possible to track cell movement over time.",
            "present new idea": "Mimi presents the idea of labeling cells ahead of time for tracking, as opposed to looking at endogenous cells, which is a new consideration in the context of the discussion."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Does a lot of papers that kind of rank sensitivity of different instruments, you know, and almost routinely. ",
        "annotations": {
            "provide supporting evidence": "Brian mentions the existence of papers that rank the sensitivity of different instruments, providing evidence to support the discussion about the capabilities of various imaging techniques for single-cell tracking."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: CT is like the worst, you know, in terms of, you know, you typically need sort of millimolar concentrations to see stuff, you know, with. ",
        "annotations": {
            "provide supporting evidence": "Brian is providing evidence to support his claim about CT's limitations, stating that millimolar concentrations are typically needed to see things, which implies low sensitivity compared to other imaging modalities discussed earlier."
        }
    },
    {
        "utterance": "Mimi Sammarco, Tulane SOM: To get a bounce, right? Yeah. ",
        "annotations": [
            {
                "express agreement": "Mimi agrees with Brian's statement that CT requires millimolar concentrations to see stuff, indicating agreement with the limitations of CT imaging."
            }
        ]
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah. ",
        "annotations": [
            {
                "express agreement": "Brian Pogue simply says 'Yeah' in response to Mimi Sammarco's comment about micro CT, indicating agreement with her point."
            }
        ]
    },
    {
        "utterance": "Brad Smith, Notre Dame: Brian just to uh talk of tools. I Allison you were um mentioned swear quantum dots. I mean I don't how far have you got are you actually doing swear imaging or is this just something you're working towards or uh. ",
        "annotations": [
            {
                "ask clarifying question": "Brad is asking Allison about the progress of her work with swear quantum dots, specifically whether she is currently doing swear imaging or if it's still in development, following up on Allison's earlier introduction of her work with semiconductor nanocrystals."
            }
        ]
    },
    {
        "utterance": "Allison Dennis, Boston U (she/her): Yeah, so we're able to send our our contrast agents to a collaborator who has both um a whole animal pre-clinical imager and the microscope our pre-clinical imager has been on order for many months and COVID delayed. ",
        "annotations": [
            {
                "acknowledge contribution": "Allison is acknowledging the contribution of a collaborator by mentioning that they are able to send contrast agents to them, which recognizes the collaborator's resources and capabilities."
            }
        ]
    },
    {
        "utterance": "Allison Dennis, Boston U (she/her): Um but we're getting a hyperspectral imager this year. Um so for us for with the QDs that's really nice because we'll be able to look we get a ton of signal out. Um the resolution for optical pre-clinical fluorescence imaging is gorgeous but background is super low. Um and with a hyperspectral we'll be able to do multi multiplex um imaging. So we'll we'll have to get the imager and push the limits on what the sensitivity is and uh how much light throughput we get of course. Um the problem with the hyperspectral is you're you're chopping up your signal so um integration times get longer. ",
        "annotations": [
            {
                "provide supporting evidence": "The speaker is providing supporting evidence for using QDs with a hyperspectral imager, stating that they get a ton of signal out, the resolution is gorgeous, and the background is super low, which strengthens the idea of using this imaging technique."
            },
            {
                "explain or define term or concept": "The speaker explains the problem with hyperspectral imaging, which is that it chops up the signal, leading to longer integration times, clarifying a limitation of the technology."
            }
        ]
    },
    {
        "utterance": "Allison Dennis, Boston U (she/her): But with the if you're doing just filter imaging the I'll show videos later there you get you can get uh you can watch the mouse breathe and then track heart rate and things because the the speed of the video frame rate is um really nice. ",
        "annotations": [
            {
                "provide supporting evidence": "Allison is providing supporting evidence for the benefits of filter imaging, stating that you can watch the mouse breathe and track heart rate due to the nice video frame rate, building on her previous description of swear quantum dots and imaging."
            }
        ]
    },
    {
        "utterance": "Allison Dennis, Boston U (she/her): So the swear imaging I'm actually a pretty big fan of and one of the things that we're looking at when you guys talk about and so I'm curious what others experiences um we don't do uh bioluminescence imaging or haven't historically. ",
        "annotations": {
            "express enthusiasm": "Allison expresses enthusiasm for swear imaging.",
            "encourage participation": "Allison expresses curiosity about others' experiences, inviting them to contribute to the discussion."
        }
    },
    {
        "utterance": "Allison Dennis, Boston U (she/her): But uh in order to be more specific about uh to focus on both the excitation and emission side we're looking at Brett probes where you would use luciferase to excite the swear emitting QDs so you don't have to worry about the excitation side of things. Um and that also gives us a handle for sensing rather than just tracking. ",
        "annotations": {
            "expand on existing idea": "Allison is building on the discussion of imaging tools by describing the use of BRET probes with luciferase to excite the swear emitting QDs, which is a more specific approach than just using QDs alone, as she mentioned she is working with swear quantum dots in the prior utterance.",
            "present new idea": "Allison introduces the idea of using BRET probes with luciferase to excite swear emitting QDs, which hasn't been mentioned before in the conversation.",
            "explain or define term or concept": "Allison explains that BRET probes use luciferase to excite swear emitting QDs, clarifying how this technique works."
        }
    },
    {
        "utterance": "Brad Smith, Notre Dame: That's an interesting one, isn't it? ",
        "annotations": {
            "acknowledge contribution": "Brad acknowledges Allison's contribution regarding the use of BRET probes with luciferase to excite the swear emitting QDs, showing interest in the idea."
        }
    },
    {
        "utterance": "Brad Smith, Notre Dame: When the the live that's one way to tell it's it's live it's producing the luminescence but actually then transfers it to the fungal wavelength reporter so you can get sort of both things coming back then, yeah. ",
        "annotations": {
            "expand on existing idea": "Brad is expanding on Allison's idea of using BRET probes, adding that the luminescence produced indicates the cell is alive and then transfers it to the fungal wavelength reporter, allowing for both pieces of information to be obtained."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: So we have um around five like seven minutes uh before the session ends. I was wondering that if we could uh start organizing our points for the spreadsheet. ",
        "annotations": {
            "propose decision": "The speaker proposes that the group start organizing their points for the spreadsheet, suggesting a concrete action for the group to take as the session is ending."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Spoken like a perfect reporter. ",
        "annotations": {
            "express humor": "Brian makes a joke after Shwetadwip suggests organizing points for the spreadsheet, implying Shwetadwip is acting like a diligent reporter."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: I mean because there there there's been like a lot of ideas around and um I definitely don't want to. ",
        "annotations": {
            "encourage participation": "Shwetadwip is trying to summarize the discussion and organize the points, which implies he wants to encourage further participation to finalize the ideas."
        }
    },
    {
        "utterance": "Ping Wang, MSU: Can you share the slide? ",
        "annotations": {
            "assign task": "Ping Wang is asking someone to share the slide, which is assigning the task of sharing the slide to someone."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: Uh yeah, sure. ",
        "annotations": [
            {
                "express agreement": "Shwetadwip Chowdhury agrees to share the slide, after Ping Wang requested it."
            }
        ]
    },
    {
        "utterance": "Allison Dennis, Boston U (she/her): It's in the Google Doc. ",
        "annotations": {
            "acknowledge contribution": "Allison is acknowledging Shwetadwip's request to share the slide by pointing out that it is already available in the Google Doc."
        }
    },
    {
        "utterance": "Allison Dennis, Boston U (she/her): It's in the Google folder too. ",
        "annotations": {
            "acknowledge contribution": "Allison is acknowledging that the location of the slide has already been mentioned by a previous speaker, Allison Dennis."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: I I can share my screen anyways, you know. ",
        "annotations": {
            "offer constructive criticism": "Shwetadwip offers to share his screen, which is a constructive suggestion to facilitate the organization of points for the spreadsheet, as requested earlier."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah, you can share your screen and then we can all sort of talk through it I guess. ",
        "annotations": {
            "encourage participation": "Brian encourages Shwetadwip to share his screen, inviting everyone to participate in the discussion and organize their points for the spreadsheet."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury, UT Austin: Yeah, we'll. ",
        "annotations": [
            {
                "encourage participation": "This utterance seems to be cut off, but given the context of organizing points for a spreadsheet and sharing the screen, it is likely that Shwetadwip is encouraging participation from the other members."
            }
        ]
    }
]